Ubs Group Ag Recursion Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 3,753,778 shares of RXRX stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,753,778

Previous 4,630,590 18.94%

Holding current value

$15.5 Million

Previous $23.4 Million 21.82%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$4.52 - $6.54 $3.96 Million - $5.73 Million	-876,812 Reduced 18.94%	3,753,778 $18.3 Million
Q2 2025 Aug 14, 2025	SELL	$3.97 - $5.84 $3.73 Million - $5.48 Million	-939,192 Reduced 16.86%	4,630,590 $23.4 Million
Q1 2025 May 13, 2025	BUY	$5.29 - $10.87 $13.6 Million - $27.9 Million	2,565,137 Added 85.37%	5,569,782 $29.5 Million
Q4 2024 Feb 14, 2025	BUY	$5.7 - $8.27 $12.6 Million - $18.2 Million	2,204,785 Added 275.65%	3,004,645 $20.3 Million
Q3 2024 Nov 14, 2024	SELL	$5.92 - $8.6 $5.03 Million - $7.3 Million	-849,190 Reduced 51.5%	799,860 $5.27 Million

Q2 2024 Aug 13, 2024	BUY	$7.35 - $10.05 $7.18 Million - $9.82 Million	976,619 Added 145.24%	1,649,050 $12.4 Million
Q1 2024 May 13, 2024	SELL	$9.13 - $15.52 $177,852 - $302,329	-19,480 Reduced 2.82%	672,431 $6.7 Million
Q4 2023 Feb 09, 2024	BUY	$5.09 - $10.79 $1.78 Million - $3.77 Million	349,232 Added 101.91%	691,911 $6.82 Million
Q3 2023 Nov 09, 2023	BUY	$6.59 - $15.86 $1.15 Million - $2.76 Million	173,954 Added 103.1%	342,679 $2.62 Million
Q2 2023 Aug 11, 2023	SELL	$4.56 - $9.94 $957 - $2,087	-210 Reduced 0.12%	168,725 $1.26 Million
Q1 2023 May 12, 2023	SELL	$6.42 - $9.64 $1.24 Million - $1.86 Million	-192,960 Reduced 53.32%	168,935 $1.13 Million
Q4 2022 Feb 08, 2023	BUY	$7.16 - $12.7 $2.46 Million - $4.36 Million	343,430 Added 1859.9%	361,895 $2.79 Million
Q3 2022 Nov 10, 2022	BUY	$7.83 - $13.6 $105,540 - $183,314	13,479 Added 270.34%	18,465 $196,000
Q2 2022 Aug 10, 2022	SELL	$5.04 - $9.26 $9,782 - $17,973	-1,941 Reduced 28.02%	4,986 $41,000
Q1 2022 May 16, 2022	SELL	$6.16 - $18.03 $1.55 Million - $4.55 Million	-252,295 Reduced 97.33%	6,927 $49,000
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $3.04 Million - $4.11 Million	188,079 Added 264.37%	259,222 $4.44 Million
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $1.34 Million - $2.91 Million	70,443 Added 10063.29%	71,143 $1.64 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $12,600 - $26,194	700 New	700 $26,000

Others Institutions Holding RXRX

# of Institutions

362

Shares Held

301M

Call Options Held

7.71M

Put Options Held

4.85M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $747M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account